Systemic Mastocytosis
Symptoms, Doctors, Treatments, Advances & More

Learn About Systemic Mastocytosis

What is the definition of Systemic Mastocytosis?

Systemic mastocytosis is a blood disorder that can affect many different body systems. Individuals with the condition can develop signs and symptoms at any age, but it usually appears after adolescence.

What are the causes of Systemic Mastocytosis?

Systemic mastocytosis occurs when white blood cells called mast cells, which are produced in bone marrow, abnormally accumulate in one or more tissues. In most cases of systemic mastocytosis, the accumulated mast cells have a mutation in a gene called KIT. The KIT gene provides instructions for making a protein that plays an important role in development and activity of mast cells. The KIT protein stimulates chemical signaling pathways that are involved in the growth and division (proliferation) of many types of cells, including mast cells. In systemic mastocytosis, KIT gene mutations are somatic, which means they are acquired during a person's lifetime. These mutations result in a KIT protein that is always turned on (activated). As a result, signaling pathways are overactive, leading to increased production and accumulation of mast cells.

How prevalent is Systemic Mastocytosis?

Systemic mastocytosis is estimated to occur in 1 per 10,000 to 20,000 individuals worldwide.

Is Systemic Mastocytosis an inherited disorder?

This condition is generally not inherited but arises from a somatic mutation in the body's cells that occurs after conception.

Who are the top Systemic Mastocytosis Local Doctors?
Elite in Systemic Mastocytosis
Internal Medicine
Elite in Systemic Mastocytosis
Internal Medicine

Domino's Farms

24 Frank Lloyd Wright Dr Ste 2100, Lobby H, 
Ann Arbor, MI 
Languages Spoken:
English, Turkish
Accepting New Patients
Offers Telehealth

Cem Akin is a primary care provider, practicing in Internal Medicine in Ann Arbor, Michigan. Dr. Akin is rated as an Elite provider by MediFind in the treatment of Systemic Mastocytosis. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Systemic Mastocytosis, Mast Cell Activation Syndrome (MCAS), Anaphylaxis, Urticaria Pigmentosa, and Tissue Biopsy. Dr. Akin is currently accepting new patients.

Distinguished in Systemic Mastocytosis
Hematology Oncology | Hematology
Distinguished in Systemic Mastocytosis
Hematology Oncology | Hematology
Referral may be required

Duke Cancer Center

20 Duke Medicine Cir, 
Durham, NC 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Carlos De Castro Iii is a Hematologist Oncology specialist and a Hematologist practicing medicine in Durham, North Carolina. Dr. De Castro Iii is rated as a Distinguished provider by MediFind in the treatment of Systemic Mastocytosis. He is also highly rated in 45 other conditions, according to our data. His clinical expertise encompasses Paroxysmal Nocturnal Hemoglobinuria (PNH), Aplastic Anemia, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration. Dr. De Castro Iii is board certified in American Board Of Internal Med, Internal Medicine. Dr. De Castro Iii is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Systemic Mastocytosis
Elite in Systemic Mastocytosis
Referral may be required

Stanford University

875 Blake Wilbur Dr, 
Palo Alto, CA 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Jason Gotlib is a Hematologist practicing medicine in Palo Alto, California. Dr. Gotlib is rated as an Elite provider by MediFind in the treatment of Systemic Mastocytosis. He is also highly rated in 42 other conditions, according to our data. His clinical expertise encompasses Systemic Mastocytosis, Mast Cell Activation Syndrome (MCAS), Myelofibrosis, Bone Marrow Aspiration, and Tissue Biopsy. Dr. Gotlib is currently accepting new patients.

What are the latest Systemic Mastocytosis Clinical Trials?
An Observational Study in Patients With Indolent Systemic Mastocytosis

Summary: This is a Phase 4, non-interventional, observational study to collect detailed data on the clinical characteristics, clinical outcomes and medical management of ISM in real-world settings. The study will describe the demographic and clinical characteristics of ISM participants, including anaphylaxis and bone manifestations in ISM. Quality of life and disease control will be assessed through partic...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Angioedema Biomarker Research Study

Summary: This clinical trial aims to evaluate and compare novel and commercially available diagnostic assays through blood tests for the differential diagnosis and comprehensive assessment of patients experiencing recurrent angioedema attacks, including both urticarial and non-urticarial angioedema. The primary objective is to assess the efficiency of novel diagnostic assays, both individually and in combi...

Who are the sources who wrote this article ?

Published Date: October 01, 2018
Published By: National Institutes of Health